NMR-based serum and urine metabolomic profile reveals suppression of mitochondrial pathways in experimental sepsis-associated acute kidney injury
Sepsis-associated acute kidney injury (SA-AKI) is a significant problem in the critically ill that causes increased death. Emerging understanding of this disease implicates metabolic dysfunction in its pathophysiology. This study sought to identify specific metabolic pathways amenable to potential therapeutic intervention. Using a murine model of sepsis, blood and tissue samples were collected for assessment of systemic inflammation, kidney function, and renal injury. Nuclear magnetic resonance (NMR)-based metabolomics quantified dozens of metabolites in serum and urine that were subsequently submitted to pathway analysis. Kidney tissue gene expression analysis confirmed the implicated pathways. Septic mice had elevated circulating levels of inflammatory cytokines and increased levels of blood urea nitrogen and creatinine, indicating both systemic inflammation and poor kidney function. Renal tissue showed only mild histological evidence of injury in sepsis. NMR metabolomic analysis identified the involvement of mitochondrial pathways associated with branched-chain amino acid metabolism, fatty acid oxidation, and de novo NAD+ biosynthesis in SA-AKI. Renal cortical gene expression of enzymes associated with those pathways was predominantly suppressed. Renal cortical fatty acid oxidation rates were lower in septic mice with high inflammation, and this correlated with higher serum creatinine levels. Similar to humans, septic mice demonstrated renal dysfunction without significant tissue disruption, pointing to metabolic derangement as an important contributor to SA-AKI pathophysiology. Metabolism of branched-chain amino acid and fatty acids and NAD+ synthesis, which all center on mitochondrial function, appeared to be suppressed. Developing interventions to activate these pathways may provide new therapeutic opportunities for SA-AKI.NEW & NOTEWORTHY NMR-based metabolomics revealed disruptions in branched-chain amino acid metabolism, fatty acid oxidation, and NAD+ synthesis in sepsis-associated acute kidney injury. These pathways represent essential processes for energy provision in renal tubular epithelial cells and may represent targetable mechanisms for therapeutic intervention.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:320 |
---|---|
Enthalten in: |
American journal of physiology. Renal physiology - 320(2021), 5 vom: 01. Mai, Seite F984-F1000 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Standage, Stephen W [VerfasserIn] |
---|
Links: |
---|
Themen: |
AYI8EX34EU |
---|
Anmerkungen: |
Date Completed 05.08.2021 Date Revised 03.05.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1152/ajprenal.00582.2020 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM323983413 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM323983413 | ||
003 | DE-627 | ||
005 | 20231225185338.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1152/ajprenal.00582.2020 |2 doi | |
028 | 5 | 2 | |a pubmed24n1079.xml |
035 | |a (DE-627)NLM323983413 | ||
035 | |a (NLM)33843271 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Standage, Stephen W |e verfasserin |4 aut | |
245 | 1 | 0 | |a NMR-based serum and urine metabolomic profile reveals suppression of mitochondrial pathways in experimental sepsis-associated acute kidney injury |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 05.08.2021 | ||
500 | |a Date Revised 03.05.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Sepsis-associated acute kidney injury (SA-AKI) is a significant problem in the critically ill that causes increased death. Emerging understanding of this disease implicates metabolic dysfunction in its pathophysiology. This study sought to identify specific metabolic pathways amenable to potential therapeutic intervention. Using a murine model of sepsis, blood and tissue samples were collected for assessment of systemic inflammation, kidney function, and renal injury. Nuclear magnetic resonance (NMR)-based metabolomics quantified dozens of metabolites in serum and urine that were subsequently submitted to pathway analysis. Kidney tissue gene expression analysis confirmed the implicated pathways. Septic mice had elevated circulating levels of inflammatory cytokines and increased levels of blood urea nitrogen and creatinine, indicating both systemic inflammation and poor kidney function. Renal tissue showed only mild histological evidence of injury in sepsis. NMR metabolomic analysis identified the involvement of mitochondrial pathways associated with branched-chain amino acid metabolism, fatty acid oxidation, and de novo NAD+ biosynthesis in SA-AKI. Renal cortical gene expression of enzymes associated with those pathways was predominantly suppressed. Renal cortical fatty acid oxidation rates were lower in septic mice with high inflammation, and this correlated with higher serum creatinine levels. Similar to humans, septic mice demonstrated renal dysfunction without significant tissue disruption, pointing to metabolic derangement as an important contributor to SA-AKI pathophysiology. Metabolism of branched-chain amino acid and fatty acids and NAD+ synthesis, which all center on mitochondrial function, appeared to be suppressed. Developing interventions to activate these pathways may provide new therapeutic opportunities for SA-AKI.NEW & NOTEWORTHY NMR-based metabolomics revealed disruptions in branched-chain amino acid metabolism, fatty acid oxidation, and NAD+ synthesis in sepsis-associated acute kidney injury. These pathways represent essential processes for energy provision in renal tubular epithelial cells and may represent targetable mechanisms for therapeutic intervention | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a acute kidney injury | |
650 | 4 | |a metabolic profiling | |
650 | 4 | |a metabolomics | |
650 | 4 | |a nuclear magnetic resonance | |
650 | 4 | |a sepsis | |
650 | 7 | |a Biomarkers |2 NLM | |
650 | 7 | |a Cytokines |2 NLM | |
650 | 7 | |a Creatinine |2 NLM | |
650 | 7 | |a AYI8EX34EU |2 NLM | |
700 | 1 | |a Xu, Shenyuan |e verfasserin |4 aut | |
700 | 1 | |a Brown, Lauren |e verfasserin |4 aut | |
700 | 1 | |a Ma, Qing |e verfasserin |4 aut | |
700 | 1 | |a Koterba, Adeleine |e verfasserin |4 aut | |
700 | 1 | |a Lahni, Patrick |e verfasserin |4 aut | |
700 | 1 | |a Devarajan, Prasad |e verfasserin |4 aut | |
700 | 1 | |a Kennedy, Michael A |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t American journal of physiology. Renal physiology |d 2000 |g 320(2021), 5 vom: 01. Mai, Seite F984-F1000 |w (DE-627)NLM105736171 |x 1522-1466 |7 nnns |
773 | 1 | 8 | |g volume:320 |g year:2021 |g number:5 |g day:01 |g month:05 |g pages:F984-F1000 |
856 | 4 | 0 | |u http://dx.doi.org/10.1152/ajprenal.00582.2020 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 320 |j 2021 |e 5 |b 01 |c 05 |h F984-F1000 |